» Articles » PMID: 22415423

Congruence of Primary Brain Tumor Patient and Caregiver Symptom Report

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2012 Mar 15
PMID 22415423
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Evaluating the severity of symptoms in patients with primary brain tumors (PBTs) is important in clinical care and research but may be difficult due to patient neurocognitive (NC) impairment. This study was conducted to evaluate the congruence of symptom reporting in patient and caregiver dyads, examining potential impact of NC impairment and Karnofsky performance status (KPS).

Methods: PBT patients undergoing NC testing and their caregivers were included in this study. These dyads (paired patient and caregiver group) completed the MD Anderson Symptom Inventory-Brain Tumor Module prior to testing, and impairment was categorized based on NC test scores. Concordance and equivalency was then assessed using Bland-Altman analysis and 2 one-sided techniques.

Results: A total of 115 dyads participated. Median patient and caregiver age was 49 and 51 years, respectively, and 63% of patients were male (73% female caregivers). Most patients had a good KPS (≥90, 66%) but were classified as NC impaired (58%). Caregiver's report of patient symptoms are congruent to the self-report of the patient. Equivalency between patient and caregiver report were found using prespecified confidence intervals. KPS group (good, ≥90; poor, ≤80) comparisons of equivalency indicated no significant differences in symptoms and interference reporting between dyads (good = 0.49, P > .05; and poor = 0.3, P > .05) overall, but there was a tendency for higher report by caregivers if the patients had a poor KPS.

Conclusions: Caregivers of PBT patients have similar assessments of symptom severity (highly congruent) with patient self-report regardless of NC function or KPS. These findings suggest that caregivers may serve as proxy report of symptoms for primary brain tumor patients.

Citing Articles

Evaluating Clinical and Sociodemographic Risk for Symptom Burden Associated Interference With Daily Functioning in the Primary Brain Tumor Patient Population.

McIver B, Davis T, Reinhart K, Vera E, Acquaye-Mallory A, Choi A Cancer Med. 2025; 14(5):e70682.

PMID: 40052556 PMC: 11886885. DOI: 10.1002/cam4.70682.


Prospective assessment of end-of-life symptoms and quality of life in patients with high-grade glioma.

Walbert T, Schultz L, Mikkelsen T, Snyder J, Phillips J, Fortunato J Neurooncol Pract. 2024; 11(6):733-739.

PMID: 39554791 PMC: 11567736. DOI: 10.1093/nop/npae056.


Self and proxy symptom reporting in glioma patient-caregiver dyads: the role of psychosocial function in rating accuracy.

Whisenant M, Snyder S, Weathers S, Bruera E, Milbury K J Patient Rep Outcomes. 2024; 8(1):74.

PMID: 39017959 PMC: 11255136. DOI: 10.1186/s41687-024-00726-8.


A novel smartphone application for the informal caregivers of cancer patients: Usability study.

Oakley-Girvan I, Yunis R, Fonda S, Neeman E, Liu R, Aghaee S PLOS Digit Health. 2023; 2(3):e0000173.

PMID: 36867639 PMC: 9983832. DOI: 10.1371/journal.pdig.0000173.


Prevalence and management of sleep disturbance in adults with primary brain tumours and their caregivers: a systematic review.

Martin J, Hart N, Bradford N, Naumann F, Pinkham M, Pinkham E J Neurooncol. 2023; 162(1):25-44.

PMID: 36864318 PMC: 10049936. DOI: 10.1007/s11060-023-04270-1.